NCT00209352View on ClinicalTrials.gov

Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 1985

Study Completion Date

July 31, 2004

Conditions
VZV Infection After Bone Marrow Transplantation
Interventions
DRUG

Acyclovir

Trial Locations (1)

98109

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

Burroughs Wellcome

INDUSTRY

collaborator

National Institutes of Health (NIH)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00209352 - Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant | Biotech Hunter | Biotech Hunter